26 related articles for article (PubMed ID: 3487462)
1. In vivo evidence of increased nNOS activity in acute MPTP neurotoxicity: a functional pharmacological MRI study.
Siow TY; Chen CC; Wan N; Chow KP; Chang C
Biomed Res Int; 2013; 2013():964034. PubMed ID: 24069609
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.
Banerjee R; Sreetama S; Saravanan KS; Dey SN; Mohanakumar KP
Neurochem Res; 2007 Jul; 32(7):1238-47. PubMed ID: 17401660
[TBL] [Abstract][Full Text] [Related]
3. Features of the parkinsonian syndrome induced experimentally by a deficit of nigrostriatal dopamine and stimulation of cholinergic neurons of the caudate nuclei.
Kryzhanovskii GN; Atadzhanov MA; Voronina TA; Nerobkova LN
Neurosci Behav Physiol; 1994; 24(6):485-8. PubMed ID: 7715769
[No Abstract] [Full Text] [Related]
4. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.
Kalaria RN; Mitchell MJ; Harik SI
Proc Natl Acad Sci U S A; 1987 May; 84(10):3521-5. PubMed ID: 3495000
[TBL] [Abstract][Full Text] [Related]
5. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
[TBL] [Abstract][Full Text] [Related]
6. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
[TBL] [Abstract][Full Text] [Related]
7. Tissue culture model for studying MPTP toxicity to dopamine neurons.
Mytilineou C; Cohen G
Adv Neurol; 1987; 45():145-8. PubMed ID: 3493622
[No Abstract] [Full Text] [Related]
8. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
9. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
[TBL] [Abstract][Full Text] [Related]
10. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
Sayre LM; Arora PK; Iacofano LA; Harik SI
Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
[TBL] [Abstract][Full Text] [Related]
11. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
Trevor AJ; Singer TP; Ramsay RR; Castagnoli N
J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Ramsay RR; McKeown K; Trevor A; Castagnoli NE
Toxicology; 1988 Apr; 49(1):17-23. PubMed ID: 3287690
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
